|
BCAP29 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.30679999999795E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.604800E-04 |
| Normal-vs-Stage2 |
1.070000E-01 |
| Normal-vs-Stage3 |
2.387800E-01 |
| Normal-vs-Stage4 |
2.353200E-01 |
| Stage1-vs-Stage2 |
4.187000E-01 |
| Stage1-vs-Stage3 |
2.852600E-01 |
| Stage1-vs-Stage4 |
6.837600E-01 |
| Stage2-vs-Stage3 |
2.281000E-01 |
| Stage2-vs-Stage4 |
3.205200E-01 |
| Stage3-vs-Stage4 |
7.466400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.622600E-04 |
| Normal-vs-AfricanAmerican |
6.740000E-03 |
| Normal-vs-Asian |
2.356000E-01 |
| Caucasian-vs-AfricanAmerican |
2.582600E-01 |
| Caucasian-vs-Asian |
3.293000E-01 |
| AfricanAmerican-vs-Asian |
8.383800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.364500E-04 |
| Normal-vs-Female |
3.843300E-04 |
| Male-vs-Female |
8.138200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.036200E-02 |
| Normal-vs-Extreme_Weight |
4.757100E-03 |
| Normal-vs-Obese |
1.972270E-02 |
| Normal-vs-Extreme_Obese |
6.396000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.919000E-01 |
| Normal_Weight-vs-Obese |
7.420000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.893600E-01 |
| Extreme_Weight-vs-Obese |
7.878000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.924600E-01 |
| Obese-vs-Extreme_Obese |
2.623400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.841800E-04 |
| Normal-vs-Age(41-60Yrs) |
4.14910000000601E-05 |
| Normal-vs-Age(61-80Yrs) |
6.484800E-03 |
| Normal-vs-Age(81-100Yrs) |
5.647200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.752400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.493600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.227200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.180000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.560200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.103800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.53040000006044E-07 |
| Normal-VS-Type2 PRCC |
5.946400E-01 |
| Normal-VS-KIRP CIMP |
2.482300E-02 |
| Normal-VS-Unclassified PRCC |
7.309600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.022400E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.425600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.902300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.948200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.617200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.840600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.355600E-01 |
| Normal-vs-N1 |
1.652250E-01 |
| Normal-vs-N2 |
6.557900E-02 |
| N0-vs-N1 |
7.713400E-01 |
| N0-vs-N2 |
5.543000E-01 |
| N1-vs-N2 |
5.870400E-01 |
|
|
